Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease

Author： Huang Rongqin   Ma Haojun   Guo Yubo   Liu Shuhuan   Kuang Yuyang   Shao Kun   Li Jianfeng   Liu Yang   Han Liang   Huang Shixian   An Sai   Ye Liya   Lou Jinning   Jiang Chen  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.30, Iss.10, 2013-10, pp. : 2549-2559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for Parkinson’s disease: review and update

By Kang U.J.   Frim D.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1551-1564

Informa Healthcare

Access to resources Recommend Favorite

Transplantation therapy for Parkinson’s disease

By Borlongan C.V.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2319-2330

Informa Healthcare

Access to resources Recommend Favorite

Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy

By Aravind Athulya  

Drug Delivery and Translational Research, Vol. 2, Iss. 6, 2012-12 ,pp. : 418-436

Springer Publishing Company

Access to resources Recommend Favorite

Chlorotoxin-Conjugated Nanoparticles for Targeted Imaging and Therapy of Glioma

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 13, 2015-01 ,pp. : 1196-1208

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term results of ADA gene therapy

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite